Financier | Commitments |
---|---|
Borrower/Recipient | 140.43 |
International Bank for Reconstruction and Development | 300.00 |
P163345
Closed
Vanina Camporeale , Marvin Ploetz
Argentine Republic
July 12, 2017
(as of board presentation)
May 18, 2018
December 17, 2018
US$ 440.43 million
National Ministry of Health
2018
US$ 300.00 million
B
Not Applicable
April 30, 2025
TBD
BANK APPROVED
May 5, 2024
Financier | Commitments |
---|---|
Borrower/Recipient | 140.43 |
International Bank for Reconstruction and Development | 300.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | 300.00 |
IDA Commitment | N/A |
IBRD + IDA Commitment | 300.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 440.43 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Apr 15, 2022 | IBRD-92220 | Int Charges | 548,933.75 |
Apr 15, 2022 | IBRD-92220 | Int Charges | 44,409.25 |
Apr 15, 2022 | IBRD-92220 | Int Charges | 1,371.53 |
Jun 15, 2022 | IBRD-88530 | Loan Disb | 3,875,097.50 |
Aug 26, 2021 | IBRD-92220 | Loan Disb | 625,000.00 |
Aug 26, 2021 | IBRD-92220 | Fee Charges | 625,000.00 |
Oct 20, 2021 | IBRD-88530 | Loan Disb | 9,143,433.00 |
Oct 22, 2021 | IBRD-92220 | Loan Disb | 47,705,968.00 |
Oct 1, 2021 | IBRD-88530 | Int Charges | 108,330.07 |
Oct 1, 2021 | IBRD-88530 | Int Charges | 1,346,220.20 |
Apr 1, 2021 | IBRD-88530 | Int Charges | 1,135,032.00 |
Apr 1, 2021 | IBRD-88530 | Int Charges | 25,383.68 |
Apr 1, 2021 | IBRD-88530 | Int Charges | 127,981.92 |
Dec 19, 2022 | IBRD-92220 | Loan Disb | 20,755,880.00 |
Oct 1, 2023 | IBRD-88530 | Int Charges | 70,406.98 |
Apr 15, 2024 | IBRD-92220 | Int Charges | 9,584.37 |
Mar 25, 2020 | IBRD-88530 | Loan Disb | 14,112,376.00 |
Aug 1, 2019 | IBRD-88530 | Loan Disb | 21,837,156.00 |
Apr 1, 2019 | IBRD-88530 | Int Charges | 8,509.38 |
Apr 1, 2019 | IBRD-88530 | Int Charges | 92,234.59 |
Apr 1, 2020 | IBRD-88530 | Int Charges | 350,195.00 |
Apr 1, 2020 | IBRD-88530 | Int Charges | 125,562.98 |
Apr 1, 2020 | IBRD-88530 | Int Charges | 212,556.95 |
Apr 1, 2020 | IBRD-88530 | Int Charges | 9,123.74 |
Apr 1, 2020 | IBRD-88530 | Int Charges | 134,011.95 |
Oct 1, 2019 | IBRD-88530 | Int Charges | 4,753.75 |
Oct 1, 2019 | IBRD-88530 | Int Charges | 365,963.60 |
Oct 1, 2019 | IBRD-88530 | Int Charges | 9,123.74 |
Aug 6, 2020 | IBRD-88530 | Loan Disb | 34,230,440.00 |
Sep 8, 2020 | IBRD-88530 | Loan Disb | 78,229,024.00 |
Oct 1, 2020 | IBRD-88530 | Int Charges | 674.77 |
Oct 1, 2020 | IBRD-88530 | Int Charges | 7,694.66 |
Oct 1, 2020 | IBRD-88530 | Int Charges | 303,741.88 |
Oct 1, 2020 | IBRD-88530 | Int Charges | 17,014.25 |
Oct 1, 2020 | IBRD-88530 | Int Charges | 371,022.12 |
Apr 12, 2021 | IBRD-88530 | Loan Disb | 22,145,932.00 |
Jul 2, 2021 | IBRD-88530 | Loan Disb | 3,430,046.50 |
Apr 1, 2021 | IBRD-88530 | Int Charges | 61,346.57 |
Apr 1, 2021 | IBRD-88530 | Int Charges | 153,365.60 |
Dec 2, 2020 | IBRD-88530 | Loan Disb | 41,893,340.00 |
Apr 15, 2022 | IBRD-92220 | Int Charges | 1,371.53 |
Oct 15, 2022 | IBRD-92220 | Int Charges | 6,297.83 |
Oct 15, 2022 | IBRD-92220 | Int Charges | 2,211,790.20 |
Sep 1, 2022 | IBRD-92220 | Loan Disb | 20,897,316.00 |
Dec 22, 2021 | IBRD-88530 | Loan Disb | 3,541,039.50 |
Dec 17, 2018 | IBRD-88530 | Loan Disb | 750,000.00 |
Dec 17, 2018 | IBRD-88530 | Fee Charges | 750,000.00 |
May 18, 2018 | IBRD-88530 | Loan Commitment | 300,000,000.00 |
Mar 30, 2021 | IBRD-92220 | Loan Commitment | 250,000,000.00 |
Apr 1, 2024 | IBRD-88530 | Int Charges | 2,688.66 |
Apr 1, 2024 | IBRD-88530 | Int Charges | 194,214.16 |
Apr 1, 2024 | IBRD-88530 | Int Charges | 57,182.65 |
Apr 1, 2024 | IBRD-88530 | Int Charges | 8,732,916.00 |
Dec 21, 2023 | IBRD-88530 | Loan Disb | 1,476,441.80 |
Dec 21, 2023 | IBRD-92220 | Loan Disb | 27,778,646.00 |
Aug 2, 2024 | IBRD-88530 | Loan Disb | 614,095.80 |
Aug 7, 2024 | IBRD-88530 | Loan Disb | 1,259,760.50 |
Jul 12, 2024 | IBRD-88530 | Loan Disb | 71,500.00 |
Apr 1, 2022 | IBRD-88530 | Int Charges | 91,295.64 |
Apr 1, 2022 | IBRD-88530 | Int Charges | 1,364,230.40 |
Apr 29, 2022 | IBRD-88530 | Loan Disb | 7,177,971.00 |
May 31, 2022 | IBRD-92220 | Loan Disb | 27,069,120.00 |
Jun 23, 2022 | IBRD-92220 | Loan Disb | 33,039,542.00 |
Apr 15, 2022 | IBRD-92220 | Int Charges | 225,144.31 |
Apr 1, 2023 | IBRD-88530 | Int Charges | 313,268.10 |
Apr 1, 2023 | IBRD-88530 | Int Charges | 74,338.44 |
Apr 1, 2023 | IBRD-88530 | Int Charges | 6,045,133.50 |
Apr 1, 2023 | IBRD-88530 | Int Charges | 74,338.44 |
Oct 1, 2022 | IBRD-88530 | Int Charges | 3,320,998.00 |
Oct 1, 2022 | IBRD-88530 | Int Charges | 78,114.13 |
Oct 15, 2022 | IBRD-92220 | Int Charges | 152,049.55 |
Dec 21, 2021 | IBRD-92220 | Loan Disb | 34,490,380.00 |
Aug 21, 2023 | IBRD-88530 | Loan Disb | 6,672,923.50 |
Aug 21, 2023 | IBRD-92220 | Loan Disb | 24,894,728.00 |
Apr 15, 2023 | IBRD-92220 | Int Charges | 78,194.65 |
May 12, 2023 | IBRD-92220 | Loan Disb | 11,971,442.00 |
May 12, 2023 | IBRD-88530 | Loan Disb | 1,697,778.50 |
Apr 15, 2023 | IBRD-92220 | Int Charges | 19,633.75 |
Apr 15, 2023 | IBRD-92220 | Int Charges | 258,031.30 |
Apr 15, 2023 | IBRD-92220 | Int Charges | 4,923,934.50 |
Apr 15, 2023 | IBRD-92220 | Int Charges | 6,297.83 |
Apr 15, 2023 | IBRD-92220 | Int Charges | 90,787.58 |
Oct 15, 2023 | IBRD-92220 | Int Charges | 44,982.03 |
Oct 15, 2023 | IBRD-92220 | Int Charges | 24,221.59 |
Oct 15, 2023 | IBRD-92220 | Int Charges | 27,173.30 |
Oct 15, 2023 | IBRD-92220 | Int Charges | 59,619.25 |
Oct 15, 2023 | IBRD-92220 | Int Charges | 6,613,833.00 |
Sep 6, 2023 | IBRD-88530 | Loan Disb | 4,758,196.00 |
Sep 6, 2023 | IBRD-92220 | Loan Disb | 771,976.00 |
Apr 1, 2024 | IBRD-88530 | Int Charges | 54,493.99 |
Apr 15, 2024 | IBRD-92220 | Int Charges | 325,131.80 |
Apr 15, 2024 | IBRD-92220 | Int Charges | 12,747.73 |
Apr 15, 2024 | IBRD-92220 | Int Charges | 3,582,120.50 |
Apr 15, 2024 | IBRD-92220 | Int Charges | 5,187,684.00 |
Aug 5, 2024 | IBRD-88530 | Loan Disb | 157,470.06 |
Aug 9, 2024 | IBRD-88530 | Loan Disb | 22,083,944.00 |
Oct 1, 2023 | IBRD-88530 | Int Charges | 139,363.73 |
Oct 1, 2023 | IBRD-88530 | Int Charges | 70,406.98 |
Oct 1, 2023 | IBRD-88530 | Int Charges | 7,552,278.00 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Satisfactory | 2025-04-28 |
Financial Management | Satisfactory | 2025-04-28 |
Monitoring and Evaluation | Satisfactory | 2025-04-28 |
Overall Implementation Progress (IP) | Satisfactory | 2025-04-28 |
Procurement | Moderately Satisfactory | 2025-04-28 |
Project Management | Satisfactory | 2025-04-28 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Percentage of eligible population with effective health coverage. | Value | 26.70 | 33.00 | 35.00 |
Date | September 29, 2017 | December 31, 2023 | December 31, 2023 | |
Comment |
Percentage of eligible population enrolled and assigned to a health facility, for continuous care (“empaneled”). | Value | 0.00 | 12.00 | 12.00 |
Date | October 31, 2017 | December 31, 2023 | December 31, 2023 | |
Comment |
Percentage of eligible adults with hypertension that are diagnosed, in regions with poorest health outcomes | Value | 0.00 | 21.50 | 18.00 |
Date | October 31, 2017 | August 31, 2023 | December 31, 2023 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Percentage of eligible pregnant women with early antenatal care. | Value | 14.70 | 38.80 | 22.00 |
Date | September 29, 2017 | August 31, 2022 | December 31, 2023 | |
Comment |
Percentage of participating provinces implementing the agreed Interoperability Plan for Information Systems. | Value | 0.00 | 91.70 | 37.50 |
Date | October 31, 2017 | December 31, 2023 | December 31, 2023 | |
Comment |
Percentage of participating provinces successfully meeting their annual IPP goals. | Value | 61.00 | 86.90 | 78.00 |
Date | December 30, 2016 | December 31, 2023 | December 31, 2023 | |
Comment |
Percentage of eligible women 25 - 64 years of age with at least one cervical cancer screening according to defined protocols. | Value | 19.60 | 17.60 | 24.00 |
Date | April 28, 2017 | September 30, 2023 | December 31, 2023 | |
Comment |
Percentage of health facilities with service delivery capacity strengthened for key lines of care, through medical equipment provision. | Value | 0.00 | 22.70 | 30.00 |
Date | October 31, 2017 | December 31, 2021 | December 31, 2023 | |
Comment |
Percentage of participating provinces implementing actions to disseminate information on the Project’s grievance redress mechanism. | Value | 54.00 | 83.30 | 79.00 |
Date | December 30, 2016 | December 31, 2023 | December 31, 2023 | |
Comment |
Percentage of eligible population with hypertension under treatment. | Value | 0.00 | 10.10 | 15.00 |
Date | November 30, 2017 | August 31, 2023 | December 31, 2023 | |
Comment |
Percentage of participating public health facilities billing to the social security institutions. | Value | 25.00 | 54.10 | 28.00 |
Date | October 31, 2017 | December 31, 2023 | December 31, 2023 | |
Comment |
Percentage of participating provinces with reported health services for selected key lines of care. | Value | 0.00 | 100.00 | 21.00 |
Date | December 6, 2017 | September 30, 2023 | December 31, 2023 | |
Comment |
Percentage of primary health care providers georreferenced and with a catchment area defined. | Value | 0.00 | 56.40 | 60.00 |
Date | October 31, 2017 | December 31, 2023 | December 31, 2023 | |
Comment |